About mi-helper

Migraine Relief My Way

Mi-Helper, Inc. collaborates with distinguished scientists and clinicians on a mission to develop cutting-edge therapies that cater to the unmet needs in pain management and mood disorders. Under the leadership of Steven Schaefer, a seasoned professional with over 30 years of experience in developing technology and life science enterprises, our team is driven to convert innovative ideas into tangible solutions that improve lives.

Our core focus revolves around the clinical study of Mi-Helper, a drug-free, non-invasive approach to pain management. This groundbreaking therapy targets pervasive and debilitating neurological conditions like Migraine and is specifically designed to provide rapid relief from the comfort of home or anywhere it is needed. With our patented technology, we strive to empower individuals with an accessible and side-effect-free solution.

Backing our ambitious endeavors, Mi-Helper, Inc. is supported by private investors and has been fortunate to receive grant support from renowned organizations such as the National Institutes of Health (NIH), Maryland Industrial Partnerships (MIPS), and the Department of Defense (DOD). Together, we are relentless in our pursuit of advancing medical science and improving the lives of individuals worldwide.


*This product has not yet been cleared or approved for use. It is currently designated for investigational use only. It should not be used outside of clinical or research settings, and its safety and effectiveness have not been fully established. Neither the manufacturer nor any associated parties assume liability for any harm or adverse events that may result from unauthorized or inappropriate use of this product.

Mi-Helper’s neuromodulation technology has the potential to be an at-home, non-invasive therapy for the treatment of migraine. Results from their prior clinical trial suggest that neuromodulation through transnasal air flow is promising, and may provide patients with relief from associated head pain and symptoms. As a longstanding advisor for Mi-Helper, I am excited to see its impact on migraine-related outcomes

Stewart J. Tepper, MD, FAHS
Vice President
The New England Institute for Neurology and Headache, Stamford, CT

Where We Started